TransMedics : Acquisition/Asset Disposal - Form 8-K
January 03, 2024 at 02:40 am IST
Share
Item 2.01.
Completion of Acquisition or Disposition of Assets.
As previously disclosed in a Current Report on Form 8-Kfiled by TransMedics Group, Inc. (the "Company") on September 5, 2023, a Current Report on Form 8-Kfiled by the Company on September 12, 2023, a Current Report on Form 8-Kfiled by the Company on September 22, 2023, a Current Report on Form 8-Kfiled by the Company on November 13, 2023 and a Current Report on Form 8-Kfiled by the Company on December 19, 2023 (together, the "Prior Reports"), TransMedics, Inc. (the "Buyer"), a Delaware corporation and wholly-owned subsidiary of the Company, acquired ten fixed-wing aircraft (collectively, the "Prior Acquisitions") as more specifically described in the Prior Reports.
Subsequently, on December 29, 2023, the Buyer acquired a fixed-wing aircraft from Embraer Executive Aircraft, Inc. (together with the Prior Acquisitions, the "Acquisitions"). The aggregate purchase price paid by the Buyer to acquire the aircraft was approximately $12.7 million, inclusive of an amount previously paid to a third party. The Company intends to use each of the 11 aircraft it has acquired to date to transport donor organs as part of the services offered under the Company's National OCS Program, and for purposes of this Current Report on Form 8-Kthe Company considers the Acquisitions to be a series of related transactions with respect to the acquisition of a fleet of aircraft for use in the Company's National OCS Program.
Transmedics Group Inc. published this content on 02 January 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 02 January 2024 21:09:05 UTC.
TransMedics Group, Inc. is a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure. The Company specializes in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Its Organ Care System (OCS) is a portable organ perfusion, optimization and monitoring system that utilizes its customized technology to replicate near-physiologic conditions for donor organs outside of the human body. It also developed its National OCS Program (NOP), which is a turnkey solution to provide outsourced organ retrieval, OCS organ management and logistics services, to provide transplant programs in the United States. Its logistics services include aviation transportation, ground transportation and other coordination activity. Its NOP provides trained organ procurement surgeons, clinical specialists and transplant coordinators that provide an end-to-end clinical solution using its OCS technology.
TRANSMEDICS GROUP, INC. 
